NPS Pharma (NPSP) Misses Q4 EPS by 8c

NPS Pharma (NASDAQ: NPSP) reported Q4 EPS of ($0.02), $0.08 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $66.7 million versus the consensus estimate of $69.3 million.

For earnings history and earnings-related data on NPS Pharma (NPSP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery